MedPath

Oral Fluency and the Response to Antidepressant Therapy in the Elderly With a Unipolar Depressive Episode

Not Applicable
Conditions
Unipolar Depression
Registration Number
NCT03227133
Lead Sponsor
Centre Hospitalier Universitaire de Besancon
Brief Summary

The study focuses on the identification of clinical, physiological and morphological markers that could predict the response to antidepressant in elderly suffering from unipolar depressive disorder.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
42
Inclusion Criteria
  • Depressive episode according to DSM-5 criteria
  • Unipolar depression
  • MADRS ≥ 20
  • Antidepressive treatment (Serotonin Reuptake Inhibitors/Serotonin Norepinephrine Reuptake Inhibitors)
Exclusion Criteria
  • Other comorbid mental disorders (bipolar disorder, schizophrenia, recent addiction < 3 months except for tobacco)
  • Depression with psychotic features
  • Serious unstabilized somatic illness
  • Protected persons
  • Dementia suspected at the time of enrollment

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Ability of the verbal fluency test score to predict the response to antidepressive treatmentweek 10

verbal fluency is assessed during the neuropsychological assessment

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Centre Hospitalier Universitaire de Besançon

🇫🇷

Besançon, France

Centre Hospitalier Universitaire de Besançon
🇫🇷Besançon, France
Julie Monnin, PhD
Contact
jmonnin@chu-besancon.fr
Caroline Masse-Sibille, MD
Principal Investigator
Emmanuel Haffen, MD, PhD
Sub Investigator
Nazim Nekrouf, MD
Sub Investigator
Pierre Vandel, MS, PhD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.